From Silicon Valley Meets San Quentin At The Last Mile Demo Day:

The Last Mile inaugural class—

The Last Mile’s inaugural class and founders. Left to right: Tulio Cardozo, E. “Phil” Phillips, James Cavitt, David Monroe, Chrisfino Kenyatta Leal, Beverly Parenti (co-founder), James Houston, Chris Redlitz (co-founder).

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

VenBio Partners Bags $394M to Back More Medicine-Making Biotechs

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

Zentalis Upsizes IPO, Raising $165M for Cancer Drug Clinical Trials

A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy

Fate Inks $100M Deal With Janssen for Stem Cell-Derived Cancer Therapies

With $80M, ReCode Looks to Advance RNA Therapies for Lung Diseases

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

Acceleron Drops Drug for Rare Muscle Disease After Mixed Phase 2 Data

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More

How San Diego Biotech Leaders Are Adapting to Coronavirus Concerns

Xcelerating Life Sciences Boston (interactive online event)

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

From Silicon Valley Meets San Quentin At The Last Mile Demo Day:

Underwriters and Partners

What to Include in Your Life Sciences Company Fundraising Pitch Deck

2019 Biopharma Outlook – Facing an Uncertain Future

How to Approach Life Sciences Fundraising

Xconomy on Demand

We offer a number of ways to subscribe for free!